Postmarketing Safety‐Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002–2014: Similarities and Differences With New Molecular Entities
Keyword(s):
2021 ◽
Vol 18
(3)
◽
pp. 464-516
2020 ◽
Keyword(s):